News

SM Energy (SM) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook gives a

The market expects Arhaus, Inc. (ARHS) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus

Excelerate Energy (EE) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook

The market expects Permian Resources (PR) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus

Acadia Pharmaceuticals (ACAD) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus

Wall Street expects a year-over-year decline in earnings on higher revenues when Acadia Healthcare (ACHC) reports results for the quarter ended December 2025. While this widely-known consensus

Wall Street expects a year-over-year decline in earnings on lower revenues when Marriott Vacations Worldwide (VAC) reports results for the quarter ended December 2025. While this widely-known

For the quarter ended December 2025, Clean Harbors (CLH) reported revenue of $1.5 billion, up 4.8% over the same period last year. EPS came in at $1.62, compared to $1.55 in the year-ago quarter.

Sabre (SABR) reported $666.53 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 6.7%. EPS of -$0.01 for the same period compares to -$0.08 a year ago.

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, February 18:

Celestica Inc. CLS: This hardware platform provider and supply chain solutions

Oatly Group AB Sponsored ADR (OTLY) closed the last trading session at $11.71, gaining 13.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Nvidia (NVDA) closed the last trading session at $184.97, gaining 3.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Sonos (SONO) closed the last trading session at $15.6, gaining 1.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Karyopharm Therapeutics (KPTI) closed the last trading session at $9.4, gaining 58% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

From a technical perspective, Scor SE (SCRYY) is looking like an interesting pick, as it just reached a key level of support. SCRYY's 50-day simple moving average crossed above its 200-day simple

Dolby Laboratories (DLB) closed the last trading session at $63.65, gaining 3.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Celanese Corporation CE reported a fourth-quarter 2025 earnings from continuing operations of 23 cents per share. This compares favorably to a loss of $17.55 in the prior-year quarter. 

Adjusted

EQT Corporation EQT reported fourth-quarter 2025 adjusted earnings from continuing operations of 90 cents per share, which beat the Zacks Consensus Estimate of 73 cents. The bottom line increased

Investors in AutoZone, Inc. AZO need to pay close attention to the stock based on moves in the options market lately. That is because the March 20, 2026 $2000.00 Call had some of the highest implied

Applied Digital APLD and Vertiv Holdings VRT operate in distinct yet converging segments of the data center infrastructure market. Vertiv provides critical power systems, thermal management and

Moody's MCO reported fourth-quarter 2025 adjusted earnings of $3.64 per share, which outpaced the Zacks Consensus Estimate of $3.46. The bottom line grew 39% from the year-ago quarter.The results

STRATA Skin Sciences, Inc. SSKN recently highlighted findings from a newly published meta-analysis that reinforces the clinical efficacy of its core 308 nm excimer laser technology in treating

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different